Isavuconazonium: first global approval.
McCormack PL.
Drugs · review; journal article · DOI 10.1007/s40265-015-0398-6 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för isavuconazonium sulfate. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
7 hitsIsavuconazonium sulfate approved for invasive fungal infections.
Traynor K.
Am J Health Syst Pharm · news · DOI 10.2146/news150027Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection model.
Seyedmousavi S, Brüggemann RJ, Meis JF, Melchers WJ, Verweij PE, Mouton JW.
Antimicrob Agents Chemother · research support, non-u.s. gov't; research-article; journal article · DOI 10.1128/aac.04907-14A phase 2, randomized, double-blind, multicenter trial to evaluate the safety and efficacy of three dosing regimens of isavuconazole compared with fluconazole in patients with uncomplicated esophageal candidiasis.
Viljoen J, Azie N, Schmitt-Hoffmann AH, Ghannoum M.
Antimicrob Agents Chemother · clinical trial, phase ii; research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.1128/aac.04586-14Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.
Seyedmousavi S, Verweij PE, Mouton JW.
Expert Rev Anti Infect Ther · review; journal article · DOI 10.1586/14787210.2015.990382Isavuconazole therapy protects immunosuppressed mice from mucormycosis.
Luo G, Gebremariam T, Lee H, Edwards JE, Kovanda L, Ibrahim AS.
Antimicrob Agents Chemother · brief-report; research support, non-u.s. gov't; journal article; research support, n.i.h., extramural · DOI 10.1128/aac.02301-13Isavuconazole (BAL4815) pharmacodynamic target determination in an in vivo murine model of invasive pulmonary aspergillosis against wild-type and cyp51 mutant isolates of Aspergillus fumigatus.
Lepak AJ, Marchillo K, Vanhecker J, Andes DR.
Antimicrob Agents Chemother · research-article; journal article · DOI 10.1128/aac.01355-13